tetradecanoylphorbol acetate has been researched along with maraviroc in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Belvisi, V; BranĂ , MT; Di Bari, G; Gramegna, P; Latronico, T; Lichtner, M; Liuzzi, GM; Mascellino, MT; Mastroianni, CM; Mengoni, F; Vullo, V | 1 |
1 other study(ies) available for tetradecanoylphorbol acetate and maraviroc
Article | Year |
---|---|
In vitro downregulation of matrix metalloproteinase-9 in rat glial cells by CCR5 antagonist maraviroc: therapeutic implication for HIV brain infection.
Topics: Animals; Astrocytes; Brain; CCR5 Receptor Antagonists; Cell Death; Cell Shape; Cell Survival; Cells, Cultured; Cyclohexanes; Down-Regulation; Gene Expression Regulation, Enzymologic; HIV Infections; Humans; Lipopolysaccharides; Maraviroc; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Neuroglia; Rats; Receptors, CCR5; RNA, Messenger; Tetradecanoylphorbol Acetate; Triazoles | 2011 |